Table 2 Period prevalence of blood pressure screening, and grade of hypertension among 1426 adults living with HIV during 2017 or 2018 seen at any one of three HIV primary care facilities in Uganda
From: Implementing screening for hypertension in archetypal HIV primary care: a mixed-methods assessment
|  | Screening N = 1426 | Stage 1 Hypertension N = 783 | Stage 2 Hypertension N = 783 |
|---|---|---|---|
Prevalence (95% CI) | Prevalence (95% CI) | Prevalence (95% CI) | |
No. Identified | 783 | 183 | 218 |
Prevalence | 55% (52 to 57) | 23% (20 to 26) | 28% (25 to 31) |
Sites | |||
 Masaka | 67% (64 to 71) | 22% (19 to 26) | 30% (26 to 34) |
 Kalisizo | 4% (1.9 to 7.4) | 13% (1.7 to 54) | 63% (24 to 87) |
 St. Balikudembe | 57% (52 to 62) | 26% (21 to 32) | 23% (18 to 29) |
Age group (Years) | |||
 18-35 | 54% (50 to 58) | 23% (19 to 28) | 16% (13 to 20) |
 36-55 | 55% (52 to 59) | 24% (20 to 29) | 35% (30 to 40) |
  > 55 | 57% (46 to 67) | 15% (7.0 to 28) | 60% (45 to 72) |